Nycomed's Instanyl® is first intranasal fentanyl approved in Europe for managing breakthrough pain in cancer
Nycomed today announced that the European Commission has granted marketing authorisation for Instanyl®, its first-in-cla…
Nycomed today announced that the European Commission has granted marketing authorisation for Instanyl®, its first-in-cla…
Nycomed today announced the appointment of Guido Oelkers as the new Executive Vice President Commercial Operations. It i…